Medicare Enrolled

Dr. Rochelle Nazarian, NP

Nurse Practitioner - Family · Danvers, MA
Low-engagement
140 COMMONWEALTH AVE, Danvers, MA 01923
9787626262
In practice since 2006 (20 years)
NPI: 1417986860 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nazarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nazarian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nazarian

Dr. Rochelle Nazarian is a nurse practitioner - family in Danvers, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Nazarian received a total of $27,010 from 56 pharmaceutical and/or device companies across 935 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nazarian is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $27,010 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$27,010
Total received (2021-2024)
Avg $6,753/year across 4 years
Top 0% in MA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
935
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,767 (84.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,243 (15.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,722
2023
$7,357
2022
$5,892
2021
$6,040

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SHIELD THERAPEUTICS INC
$4,082
AstraZeneca Pharmaceuticals LP
$693
ABBVIE INC.
$605
Lilly USA, LLC
$304
Amgen Inc.
$294
Otsuka America Pharmaceutical, Inc.
$259
Bayer Healthcare Pharmaceuticals Inc.
$235
PFIZER INC.
$157
Novo Nordisk Inc
$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$150
GlaxoSmithKline, LLC.
$140
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$123
Astellas Pharma US Inc
$101
Exact Sciences Corporation
$97
Phathom Pharmaceuticals, Inc.
$74
Merck Sharp & Dohme LLC
$68
Ardelyx, Inc.
$44
Lundbeck LLC
$28
Abbott Laboratories
$23
Novartis Pharmaceuticals Corporation
$20
Inspire Medical Systems, Inc.
$18
Gilead Sciences, Inc.
$18
Lucid Diagnostics Inc.
$17
Echosens North America, Inc.
$16
Top 3 companies account for 69.7% of 2024 payments
All-time payments by company (2021-2024) ›
SHIELD THERAPEUTICS INC
$4,082
ABBVIE INC.
$3,244
AstraZeneca Pharmaceuticals LP
$3,094
Shield Therapeutics Inc
$2,459
Amgen Inc.
$1,549
AbbVie Inc.
$1,334
Novo Nordisk Inc
$1,334
Lilly USA, LLC
$1,049
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$710
Bayer Healthcare Pharmaceuticals Inc.
$613
Corium, LLC
$584
Boehringer Ingelheim Pharmaceuticals, Inc.
$549
GlaxoSmithKline, LLC.
$549
Biohaven Pharmaceuticals, Inc.
$526
Biohaven Pharmaceutical Holding Company Ltd.
$488
Astellas Pharma US Inc
$370
IDORSIA PHARMACEUTICALS US INC
$350
Janssen Pharmaceuticals, Inc
$343
RedHill Biopharma Inc.
$341
Bayer HealthCare Pharmaceuticals Inc.
$341
Otsuka America Pharmaceutical, Inc.
$336
PFIZER INC.
$307
Novartis Pharmaceuticals Corporation
$261
Amarin Pharma Inc.
$254
Merck Sharp & Dohme LLC
$207
Alkermes, Inc.
$156
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$150
Galderma Laboratories, L.P.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$128
Exact Sciences Corporation
$113
Sunovion Pharmaceuticals Inc.
$98
Merck Sharp & Dohme Corporation
$93
Eisai Inc.
$84
Nestle HealthCare Nutrition Inc.
$75
Phathom Pharmaceuticals, Inc.
$74
QOL Medical, LLC
$71
Mylan Specialty L.P.
$58
Ironwood Pharmaceuticals, Inc
$57
Genentech USA, Inc.
$53
Ardelyx, Inc.
$44
Esperion Therapeutics, Inc.
$44
ITI, Inc.
$42
Lundbeck LLC
$28
NESTLE HEALTHCARE NUTRITION INC.
$27
SANOFI-AVENTIS U.S. LLC
$23
Abbott Laboratories
$23
EISAI INC.
$19
Inspire Medical Systems, Inc.
$18
Gilead Sciences, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$17
Lucid Diagnostics Inc.
$17
Echosens North America, Inc.
$16
Biogen, Inc.
$15
TherapeuticsMD, Inc.
$15
Hikma Pharmaceuticals USA
$14
Eyevance Pharmaceuticals LLC
$14
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · ADUHELM · AIRSUPRA · ANNOVERA · ANORO ELLIPTA · AREXVY · ARISTADA · AZSTARYS · Aimovig · Azstarys · BAQSIMI · BELSOMRA · BEXSERO · BOTOX · BREZTRI · BRILINTA · CAPLYTA · COMIRNATY · CREON · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · FibroScan · GARDASIL · GARDASIL 9 · GEMTESA · IBSRELA · INSPIRE · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOKELMA · LYBALVI · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYRBETRIQ · Mitigare · Movantik · Myrbetriq · NEXLETOL · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SUCRAID · Saxenda · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TRUMENBA · Talicia · Tobradex ST · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · XARELTO · XIFAXAN · Xofluza · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 0% for nurse practitioner - family in MA.

Looking for a nurse practitioner - family in Danvers?
Compare family nurse practitioners in the Danvers area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
2,155
Per 100K population
267.0
County median income
$99,431
Nearest hospital
NORTHEAST HOSPITAL CORPORATION
4.2 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nazarian is a nurse practitioner - family, with low-engagement industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Nazarian receive payments from pharmaceutical companies?
Yes. Dr. Nazarian received a total of $27,010 from 56 companies across 935 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Nazarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Danvers
Browse family nurse practitioners in Danvers ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in MA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in MA
Which MA family nurse practitioners receive the most from drug and device companies.
By company
SHIELD THERAPEUTICS INC Payments to Doctors
See all physicians who received payments from SHIELD THERAPEUTICS INC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →